טוען...
Bempedoic acid for the treatment of dyslipidemia
Cardiovascular disease (CVD) is the leading cause of death worldwide and one key factor associated with the increased CVD risk is dyslipidemia. Statin therapy remains the first-line treatment to manage dyslipidemia, yet many patients do not achieve optimal low-density lipoprotein-cholesterol (LDL-C)...
שמור ב:
| הוצא לאור ב: | Drugs Context |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioExcel Publishing Ltd
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7449648/ https://ncbi.nlm.nih.gov/pubmed/32922503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.2020-6-5 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|